Industry news
Valeant to respond to allegations in conference call on 26 October
The suggestion has been made that Valeant Pharma has been booking revenue under the name of specialty pharmacies. Valeant had disclosed a relationship with Philidor Rx Services and possible litigation with R&O Pharmacy. The effect on the Valeant share price has been dramatic and there are calls for Valeant to improve transparency. Valeant will now host a conference call on October 26 to contest the allegations.